Am J Transplant, Volume 17, Suppl 3 Archives - ATC Abstracts

2017 American Transplant Congress
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.
N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ A. Bello,¹ S. Klarenbach.¹
¹University of Alberta, Edmonton, Canada; ²University of Calgary, Calgary, Canada; ³Saint Louis University, St. Louis
The risk of mortality and graft loss is higher in kidney transplant recipients with reduced estimated glomerular filtration rate (eGFR) and heavier albuminuria. It is…
2017 American Transplant Congress
Primary Hyperoxaluria Type-1 in Chinese Population: A Case Series and Review of Literature.
D. Du,^1,2 Q. Li,^1,2 H. Shi,^1,2 S. Chen,^1,2 B. Liu,^1,2 Z. Lin,^1,2 G. Chen,^1,2 F. Zeng,^1,2 W. Zhang,^1,2 Z. Chen.^1,2
¹Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; ²Key Laboratory of Organ Transplantation, Ministry of Health/Education, Wuhan, Hubei, China
Background: Primary hyperoxaluria type 1 (PH1) is rare but devastating autosomal recessive inherited disease and cause to graft failure after kidney transplant (KT). We report…
2017 American Transplant Congress
Intraoperative Fluid Management During Pediatric Kidney Transplantation with Less Than 15kg Body Weight Using Transesophageal Echocardiaography as Hemodynamic Parameter.
Y. Watarai,¹ S. Narumi,¹ R. Kimura,¹ K. Hatazoe,¹ M. Okada,¹ K. Futamura,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ Y. Goto.²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan; ²Pediatric Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
Introduction: To avoid low output syndrome (LOS) and delayed graft function (DGF), precise intraoperative hemodynamic monitoring are mandatory for small pediatric recipients with adults' donor…
2017 American Transplant Congress
Does Simultaneous Liver Kidney Transplant in Patients with MELD ≥35 on Renal Replacement Therapy at the Time of Transplant Improve Outcome?
B. Ali, C. Gadiparthi, G. Cholankeril, S. Satapathy, J. Eason, S. Nair.
Transplant Hepatology, Univ. of Tennessee, Memphis, TN
Background: A significant proportion of patients with MELD ≥35 have renal failure requiring renal replacement therapy (RRT) at the time of transplant, and receive either…
2017 American Transplant Congress
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.
S. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ R. Saxena,² N. Rush,² N. Higgins,⁴ M. Ghabril,³ M. Lacerda,³ A. Lobashevsky.⁴
¹Department of Surgery, Division of Transplantation, Indiana University School of Medicine, Indianapolis, IN; ²Department of Pathology, Indiana University School of Medicine, Indianapolis, IN; ³Department of Gastroenterology, Division of Hepatology, Indiana University School of Medicine, Indianapolis, IN; ⁴Department of Medicine, Immunology/Histocompatibility Laboratory, Indiana University School of Medicine, Indianapolis, IN
Background: Post transplant course of circulating de novo donor specific antibodies (DSA) remains unknown after liver transplantation (LT).Methods: In a prospective study, sera from 92…
2017 American Transplant Congress
Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.
A. Hooper,¹ C. Frenette.²
¹Internal Medicine, Scripps Mercy Hospital, San Diego, CA; ²Organ Transplant, Scripps Green Hospital, La Jolla, CA
Immunosuppression regimens in patients with end stage liver disease (ESLD) from autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) typically include…
2017 American Transplant Congress
Sensitized KPD Pairs Take Longer to Find Matches.
C. Holscher,¹ E. Chow,¹ C. Purcell,² M. Ronin,² J. Garonzik-Wang,¹ A. Massie,¹ S. Gentry,³ D. Segev.¹
¹Johns Hopkins University, Baltimore; ²National Kidney Registry, New York; ³US Naval Academy, Annapolis
Kidney paired donation (KPD) can facilitate living donor transplantation for candidates with an incompatible donor, but it is unclear how sensitization or blood type affects…
2017 American Transplant Congress
African American Living Kidney Donors' Attitudes About APOL1 Genetic Testing: Implications for Evaluation and Informed Consent.
E. Gordon,¹ C. Johnson,¹ C. Wicklund,¹ R. Sharp,² J. Friedewald.¹
¹Northwestern University, Chicago, IL; ²Mayo Clinic, Rochester
BackgroundAfrican American (AA) live kidney donors (LKDs) have a greater risk than European American live donors of kidney failure. Apolipoprotein 1 (APOL1) gene variants in…
2017 American Transplant Congress
Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.
E. Giorgakis,¹ R. Heilman,² H. Khamash,² B. Kaplan,² A. Moss,¹ M. Smith,³ K. Reddy.¹
¹Department of Surgery, Mayo Clinic, Phoenix, AZ; ²Department of Medicine, Mayo Clinic, Phoenix, AZ; ³Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
Purpose of the study was to explore the effect of admit AKI donor creatinine on graft outcomes.Method: Single center retrospective analysis of kidney transplants performed…
2017 American Transplant Congress
Screening and Referral of High Risk Liver Transplant Recipients to a Transitional Care Coordination (TCC) Program to Reduce Hospital Readmissions.
A. Masoumi,¹ J. Krzyzewski,¹ T. Stern,¹ N. Schluterman,² D. Bruno,² J. Bromberg,² R. Barth,² S. Hanish.²
¹University of Maryland Medical Center, Baltimore, MD; ²University of Maryland School of Medicine, Baltimore, MD
Introduction One-fifth of Medicare patients are readmitted to the hospital. The readmission rate among liver transplant recipients at a large tertiary academic medical center in…

1
2
3
…
181
Next Page »